LENTIVERSE
Live / Applied — Statement of use — registration review complete (as of 08 Oct 2026)
What this means for you
Not registered yet, but its 28 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98425786
- Mark type
- Word mark
- Filed
- 28 Feb 2024
- Published for opposition
- 10 Dec 2024
- Attorney of record
- Mark Leonardo
Goods and services
- Class 042 — Scientific and technological services: Platform as a service (PAAS) featuring computer software platforms related to gene therapy carrier vectors, namely, computer software platforms using artificial intelligence for designing lentivirus vectors, designing lentivirus vectors that target specific cell types, designing lentivirus vector packaging cell lines, creating and managing manufacturing processes, conducting quality assurance process validation reviews, and generating reports about lentivirus vectors and manufacturing processes for use during characterization of new products for commercial approval
Owner
- Vector BioMed Inc, Gaithersburg, MD, US
- Vector BioMed Inc, Gaithersburg, MD, US
Prosecution history
- 08 Oct 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Oct 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Aug 2026 — ASSIGNED TO EXAMINER
- 18 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Jun 2026 — USE AMENDMENT FILED
- 28 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
- 03 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Feb 2026 — SOU EXTENSION 2 GRANTED
- 02 Feb 2026 — SOU EXTENSION 2 FILED
- 02 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 31 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jul 2025 — SOU EXTENSION 1 GRANTED
- 30 Jul 2025 — SOU EXTENSION 1 FILED
- 30 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT